Recent advances in neurokinin-3 receptor antagonists

Expert Opinion on Therapeutic Patents

Volumn 10, Issue 6, 2000, Pages 939-960

  Giardina, G A M ^a   Grugni, M ^a   Raveglia, L F ^a  

^a SmithKline Beecham   (Italy)

Author keywords

Anxiety; Dichlorophenylalkylpiperidines; Gastrointestinal tract diseases; Inflammation; Neurokinin B; Neurokinin 3 receptor antagonists; Pain; Pulmonary diseases; Quinolines; SB 222200; SB 223412; Senktide; SR 142,801

Indexed keywords

N (ALPHA ETHYLBENZYL) 3 METHYL 2 PHENYL 4 QUINOLINECARBOXAMIDE; NEUROKININ 3 RECEPTOR; NEUROKININ 3 RECEPTOR ANTAGONIST; OSANETANT; PIPERIDINE DERIVATIVE; QUINOLINE DERIVATIVE; R 820; SENKTIDE; TALNETANT; UNCLASSIFIED DRUG;

ANXIETY NEUROSIS; DRUG BINDING; DRUG STRUCTURE; GASTROINTESTINAL DISEASE; INFLAMMATION; LUNG DISEASE; NONHUMAN; PAIN; RECEPTOR BLOCKING; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0034110652     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.10.6.939     Document Type: Review

References (57)